BIO
Lev Gertsik
Medical Director, Clinical Trials Medical Group, Los Angeles Early Phase Clinical Unit
A member of the Parexel team since 2004, Lev serves as Medical Director of the Clinical Trials Medical Group at the Los Angeles Early Phase Clinical Unit. He is recognized in the industry for his expertise in study design, protocol development, and research methodologies for central nervous system clinical studies.
Work Experience
Lev has more than 20 years of experience in psychiatric research. He has served as principal investigator, sub-investigator, and designer of Phase I to IV evaluations of medications for psychiatric and neurological disorders, including schizophrenia; mood, anxiety, and sleep disorders; and Alzheimer’s disease. He has extensive experience employing bio- and surrogate markers, imaging, behavioral, and neuropsychiatric and cognitive assessments into target patient populations studies. He also has broad expertise conductive ethnic sensitivity, bioequivalence, and drug-drug interaction studies, as well as investigator and rater training.
Education
Lev earned his medical degree in psychiatry from the Moscow Medical and Stomatological Institute, Moscow, Russia.